VEGF-IN-1
VEGF-IN-1 (compound 6) can reduce the release of VEGF in U87-MG cells and inhibit angiogenesis in vitro. VEGF-IN-1 can inhibit cell proliferation by inducing autophagy in tumor cells, with an IC50 value of 28.35 μM for U87-MG cells[1].
Product Specifications
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vegf-in-1.html
Smiles
CC(C=C1)=CC=C1C2=NC3=C(N2)C4=C(C5=C3C=CC=[N]5[Ru]6([])Cl)[N]6=CC=C4.Cc7ccccc7.[Cl-]
Molecular Formula
C27H22Cl2N4Ru
Molecular Weight
574.47
References & Citations
[1]Yuan C, et al. Discovery of Arene Ruthenium (II) Complexes as Potential VEGF Inhibitors for Glioblastoma Metastasis Suppression. J Med Chem. 2024 Nov 14;67 (21) :18724-18740.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15152661 1 Vial
Lentiviral human TFB2M shRNA (UAS) - Lentiviral human TFB2M shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
MBS6491814-01 0.1 mL
PAK2, CT (p21 Activated Kinase 2, p21-activated Kinase 2, p21(CDKN1A)-activated Kinase 2, PAK-2, CB422, Gamma PAK, hPAK65, p65-PAK, PAK65, PAKgamma, S6/H4 Kinase, Serine/threonine Protein Kinase PAK 2) (Biotin)
Sign In for Pricing
View Details 
MBS6491814-02 5x 0.1 mL
PAK2, CT (p21 Activated Kinase 2, p21-activated Kinase 2, p21(CDKN1A)-activated Kinase 2, PAK-2, CB422, Gamma PAK, hPAK65, p65-PAK, PAK65, PAKgamma, S6/H4 Kinase, Serine/threonine Protein Kinase PAK 2) (Biotin)
Sign In for Pricing
View Details 
GTR15186016 1 Vial
Lentiviral mouse Rilpl1 shRNA (UAS) - Lentiviral mouse Rilpl1 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details